Literature DB >> 15556161

From inhibition to excitation: functional effects of interaction between opioid receptors.

Andrew C Charles1, Tim G Hales.   

Abstract

Opioids have excitatory effects in multiple regions of the nervous system. Excitation by opioids is generally attributed to inhibition of inhibitory pathways (disinhibition). However, recent studies indicate that opioids can directly excite individual cells. These effects may occur when opioid receptors interact with other G protein coupled receptors, when different subtypes of opioid receptors interact, or when opioids transactivate other receptors such as receptor tyrosine kinases. Changes in the relative level of expression of different receptors in an individual cell may therefore determine its functional response to a given ligand. This phenomenon could represent an adaptive mechanism involved in tolerance, dependence and subsequent withdrawal.

Mesh:

Substances:

Year:  2004        PMID: 15556161     DOI: 10.1016/j.lfs.2004.09.012

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  7 in total

1.  Stimulation of δ opioid receptor and blockade of nociceptin/orphanin FQ receptor synergistically attenuate parkinsonism.

Authors:  Omar S Mabrouk; Riccardo Viaro; Mattia Volta; Ada Ledonne; Nicola Mercuri; Michele Morari
Journal:  J Neurosci       Date:  2014-09-24       Impact factor: 6.167

2.  In vitro and in vivo functional profile characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3-carboxamido)morphinan (NAQ) as a low efficacy mu opioid receptor modulator.

Authors:  Samuel Obeng; Yunyun Yuan; Abdulmajeed Jali; Dana E Selley; Yan Zhang
Journal:  Eur J Pharmacol       Date:  2018-03-09       Impact factor: 4.432

3.  Inhibition of morphine-induced cAMP overshoot: a cell-based assay model in a high-throughput format.

Authors:  Menghang Xia; Vicky Guo; Ruili Huang; Sampada A Shahane; Christopher P Austin; Marshall Nirenberg; Shail K Sharma
Journal:  Cell Mol Neurobiol       Date:  2011-05-20       Impact factor: 5.046

4.  Behavioral and cellular pharmacology characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3'-carboxamido)morphinan (NAQ) as a mu opioid receptor selective ligand.

Authors:  Yan Zhang; Amanda Braithwaite; Yunyun Yuan; John M Streicher; Edward J Bilsky
Journal:  Eur J Pharmacol       Date:  2014-05-08       Impact factor: 4.432

5.  Cholecystokinin receptor-1 mediates the inhibitory effects of exogenous cholecystokinin octapeptide on cellular morphine dependence.

Authors:  Di Wen; Chun-Ling Ma; Ya-Jing Zhang; Yan-Xin Meng; Zhi-Yu Ni; Shu-Jin Li; Bin Cong
Journal:  BMC Neurosci       Date:  2012-06-08       Impact factor: 3.288

Review 6.  Shared mechanisms of alcohol and other drugs.

Authors:  Maureen T Cruz; Michal Bajo; Paul Schweitzer; Marisa Roberto
Journal:  Alcohol Res Health       Date:  2008

7.  Over-expression of CCK1 Receptor Reverse Morphine Dependence.

Authors:  Lijing Hao; Di Wen; Hongyan Gou; Feng Yu; Bin Cong; Chunling Ma
Journal:  Int J Pept Res Ther       Date:  2018-04-02       Impact factor: 1.931

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.